iCAD (ICAD) Upgraded by ValuEngine to “Sell”

ValuEngine upgraded shares of iCAD (NASDAQ:ICAD) from a strong sell rating to a sell rating in a research note issued to investors on Thursday morning.

Shares of iCAD (NASDAQ:ICAD) traded up $0.44 on Thursday, reaching $4.00. The company’s stock had a trading volume of 78,000 shares, compared to its average volume of 61,067. The firm has a market cap of $65.44, a P/E ratio of -4.88 and a beta of 1.54. iCAD has a 52-week low of $3.13 and a 52-week high of $6.07. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.95 and a quick ratio of 1.67.

iCAD (NASDAQ:ICAD) last announced its earnings results on Wednesday, November 8th. The technology company reported ($0.13) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.14) by $0.01. The firm had revenue of $7.00 million for the quarter, compared to the consensus estimate of $7.43 million. iCAD had a negative return on equity of 47.31% and a negative net margin of 49.16%. equities research analysts forecast that iCAD will post -0.62 EPS for the current fiscal year.

Institutional investors and hedge funds have recently made changes to their positions in the business. Segall Bryant & Hamill LLC bought a new position in shares of iCAD in the 3rd quarter worth about $133,000. Dimensional Fund Advisors LP raised its position in shares of iCAD by 165.1% in the 3rd quarter. Dimensional Fund Advisors LP now owns 89,043 shares of the technology company’s stock worth $394,000 after acquiring an additional 55,455 shares in the last quarter. Vanguard Group Inc. raised its position in shares of iCAD by 0.4% in the 2nd quarter. Vanguard Group Inc. now owns 456,377 shares of the technology company’s stock worth $1,912,000 after acquiring an additional 2,007 shares in the last quarter. Finally, Argent Capital Management LLC raised its position in shares of iCAD by 13.2% in the 2nd quarter. Argent Capital Management LLC now owns 713,650 shares of the technology company’s stock worth $2,990,000 after acquiring an additional 82,967 shares in the last quarter. 21.98% of the stock is currently owned by hedge funds and other institutional investors.

WARNING: This report was originally reported by Ticker Report and is the property of of Ticker Report. If you are reading this report on another publication, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The original version of this report can be read at https://www.tickerreport.com/banking-finance/3127350/icad-icad-upgraded-by-valuengine-to-sell.html.

iCAD Company Profile

iCAD, Inc is a provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer. The Company provides image analysis and clinical decision support solutions for mammography, Magnetic Resonance Imaging and Computed Tomography imaging. It operates in two segments: Cancer Detection (Detection) and Cancer Therapy (Therapy).

Receive News & Ratings for iCAD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iCAD and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


© 2006-2018 Ticker Report. Google+.